about
The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's DiseaseNeuroinflammation in Alzheimer's disease: chemokines produced by astrocytes and chemokine receptorsBrain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogsOxidized cholesterol as the driving force behind the development of Alzheimer's diseaseExploring Biomarkers for Alzheimer's DiseaseLoading into nanoparticles improves quercetin's efficacy in preventing neuroinflammation induced by oxysterolsOridonin attenuates Aβ1-42-induced neuroinflammation and inhibits NF-κB pathwayChronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of ADA Bacterial Component to Alzheimer’s-Type Dementia Seen via a Systems Biology Approach that Links Iron Dysregulation and Inflammagen Shedding to DiseaseSmall molecule p75NTR ligands reduce pathological phosphorylation and misfolding of tau, inflammatory changes, cholinergic degeneration, and cognitive deficits in AβPP(L/S) transgenic mice.Human neural stem cells alleviate Alzheimer-like pathology in a mouse model.Possible modification of Alzheimer's disease by statins in midlife: interactions with genetic and non-genetic risk factorsMetabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: Alleviation by pantethine.The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease.Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer's disease (AD) and in primary human neuronal-glial (HNG) cellsSphingosine 1-phosphate receptor 3 and RhoA signaling mediate inflammatory gene expression in astrocytes.γ-Secretase inhibition of murine choroidal neovascularization is associated with reduction of superoxide and proinflammatory cytokines.Longitudinal follow-up of autophagy and inflammation in brain of APPswePS1dE9 transgenic miceThe diagnosis and evaluation of dementia and mild cognitive impairment with emphasis on SPECT perfusion neuroimaging.Inflammasomes in neuroinflammation and changes in brain function: a focused review.Cellular prion protein and NMDA receptor modulation: protecting against excitotoxicity.Developing novel blood-based biomarkers for Alzheimer's diseasePalmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-αIntravenous immunglobulin binds beta amyloid and modifies its aggregation, neurotoxicity and microglial phagocytosis in vitro.Th17 cell-mediated neuroinflammation is involved in neurodegeneration of aβ1-42-induced Alzheimer's disease model rats.Protection of TGF-β1 against neuroinflammation and neurodegeneration in Aβ1-42-induced Alzheimer's disease model rats.Loss of the receptor tyrosine kinase Axl leads to enhanced inflammation in the CNS and delayed removal of myelin debris during experimental autoimmune encephalomyelitisIsoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer's disease.CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer's disease model.The contribution of activated astrocytes to Aβ production: implications for Alzheimer's disease pathogenesisEvaluation of inflammation-related genes polymorphisms in Mexican with Alzheimer's disease: a pilot study.C-Reactive Protein Induces Tau Hyperphosphorylation via GSK3β Signaling Pathway in SH-SY5Y Cells.Toxoplasma gondii infection in the brain inhibits neuronal degeneration and learning and memory impairments in a murine model of Alzheimer's disease.An apolipoprotein E4 fragment affects matrix metalloproteinase 9, tissue inhibitor of metalloproteinase 1 and cytokine levels in brain cell lines.Brain metabolic dysfunction at the core of Alzheimer's disease.Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 MiceThe antimicrobial protein, CAP37, is upregulated in pyramidal neurons during Alzheimer's disease.Noninvasive molecular imaging of neuroinflammationForebrain microglia from wild-type but not adult 5xFAD mice prevent amyloid-β plaque formation in organotypic hippocampal slice cultures.The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease.
P2860
Q26781815-FF492B7C-3A5B-496C-BE2A-E1F94F194817Q26995483-AAC1BF48-BC3A-4F1E-AABD-7B8F57596AAEQ27012801-BD7FDE67-C0C9-4463-B19A-CC4D8F5F0CAEQ27023315-F65EE41A-0082-475B-9BEF-AFFE4F921F20Q28079218-AA229211-9171-4808-BC34-FCABEB91FC75Q28538558-8CEFC407-D782-4E58-A7E0-7CFB2D73E9B5Q28541946-A90FB27D-CFD6-4604-B643-B6D8EE69B9A7Q28547449-B0D8B348-1A70-4E94-AA5F-E28D926FE2B3Q29248210-EB1947CF-32A2-4477-8529-995912771DD9Q30611779-2B162706-8568-47A0-8C4A-850496EEC5F3Q30662068-77A38533-7F6E-4288-9B26-91EF0122F979Q30814231-8DA732E8-E5B0-4154-BBC1-A0EA06250AACQ33565510-45DB1B2B-3240-42F4-8E91-728260926448Q33600053-B5D5B4A6-E29E-442F-9936-DF59F1F150D1Q33686370-DA42AF7C-2B5A-43B3-AD2F-2C4C5A3A650DQ33756197-0AEB9490-7D82-46D3-94B0-A79FD18A08BEQ34113394-8CC9F624-FBD4-41A0-8E05-CE4AF1428348Q34133074-F73377F0-ED2C-40AF-AF2E-55C28F777917Q34296479-DE2BD1CB-A76E-4ABC-9909-CAFC6C89925EQ34299338-F299A0C9-EC1D-448D-9A20-96B0702EA1E1Q34391341-858CC4FE-6D8D-4A89-A246-6E32838E388EQ34394080-5F949495-4611-430B-A1FD-4D40760629F8Q34636570-D2AA91C4-B492-499D-86B0-762EC66DCA61Q34733689-A0A4B61C-359C-4747-B901-833DEEF09CA4Q35016821-6EBEB40F-8434-49FC-B814-A665997A3555Q35058396-FEEE1389-B3C4-466C-B68A-C6B5B307F46EQ35063750-41D5F18A-1509-4B94-A730-D91A183FA16FQ35197124-D3EF7AEF-0181-4164-B7A3-378EF0689EAAQ35242410-C56339EB-5EFB-49E2-8CC8-261C130B7DF6Q35549855-5A859C62-2632-4CAC-A7C4-F6B668EB0C16Q35617592-A6A7BF00-CCC1-490F-A767-EFB13B1FE862Q35628333-CFF3FEBC-8165-40F5-AF6A-72E1FE88BBC1Q35845728-B7E5426E-81D7-431F-B188-E1A79E118A5CQ35981432-C98B91C0-1824-4643-B0B2-2B5AD2C503A8Q35997881-AE962B3C-01FA-4AE8-B9EB-E18813D92526Q36065117-D9BBDDA8-F3E8-456C-A496-1DB778FE7B7EQ36073680-FE65E2BB-4720-4724-ABC6-0B9CB888FA84Q36079268-75D58E6A-F04A-430F-813F-42EC4C175937Q36102782-6602961E-D671-4FA3-904E-745EA78132E2Q36191996-02A70945-6555-45D4-87B9-C882C3733B9B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neuroinflammatory processes in Alzheimer's disease.
@en
Neuroinflammatory processes in Alzheimer's disease.
@nl
type
label
Neuroinflammatory processes in Alzheimer's disease.
@en
Neuroinflammatory processes in Alzheimer's disease.
@nl
prefLabel
Neuroinflammatory processes in Alzheimer's disease.
@en
Neuroinflammatory processes in Alzheimer's disease.
@nl
P2093
P2860
P1476
Neuroinflammatory processes in Alzheimer's disease.
@en
P2093
Dick Terwel
M Kerry O'Banion
Michael T Heneka
P2860
P2888
P304
P356
10.1007/S00702-010-0438-Z
P577
2010-07-15T00:00:00Z